Loading…
Venus Medtech Inc., a Chinese transcatheter heart valve company, has signed an agreement to acquire Keystone Heart Ltd., a medical device company that makes the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to TriGUARD 3 and establishes its presence in the US and EMEA.
Venus Medtech signed an agreement to acquire Keystone Heart Ltd., a medical device company making the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to the device and establishes a presence in the US and EMEA.